›› 2019, Vol. 39 ›› Issue (8): 919-.doi: 10.3969/j.issn.1674-8115.2019.08.019
• Review • Previous Articles Next Articles
REN Yan-yan, WANG Zhen
Online:
Published:
Supported by:
Abstract: Administration of selective serotonin reuptake inhibitors (SSRI) is a widely used pharmacotherapeutic approach for obsessive-compulsive disorder (OCD) today. However, nearly half of the OCD patients do not respond to SSRI. It has been shown that some antipsychotic drugs can augment the therapeutic effect of SSRI in the patients with OCD, but the augmentation’s effect is still ineffective for some patients.Therefore, it is of great significance to explore the augmentation’s mechanism for further improvement of the clinical treatment. This article reviews some common used augmentation for OCD and discusses the underlying mechanisms.
Key words: obsessive compulsive disorder (OCD), augmentation, selective serotonin reuptake inhibitor (SSRI), antipsychotics
CLC Number:
R749.053
REN Yan-yan, WANG Zhen. Progress in augmentation therapy mechanism of obsessive compulsive disorder[J]. , 2019, 39(8): 919-.
0 / / Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: https://xuebao.shsmu.edu.cn/EN/10.3969/j.issn.1674-8115.2019.08.019
https://xuebao.shsmu.edu.cn/EN/Y2019/V39/I8/919